NCT03608644

Brief Summary

Predictive factors of outcome of mechanical thrombectomy after acute ischemic stroke

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

October 30, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2020

Completed
Last Updated

August 2, 2018

Status Verified

August 1, 2018

Enrollment Period

4 months

First QC Date

July 9, 2018

Last Update Submit

August 1, 2018

Conditions

Acute Ischemic Stroke

Outcome Measures

Primary Outcomes (1)

  • The outcomes of mechanical thrombectomy after acute ischemic stroke within three months

    Modified Rankin Scale (mRS) for measuring the degree of disability

    3 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with acute ischemic stroke

You may qualify if:

  • Age \>18 years
  • Cerebral infarction in the anterior or posterior circulation (intracranial internal carotid artery, M1 or M2 middle cerebral artery, basilar or vertebral arteries) proven by Computed tomography angiography
  • With or without intravenous thrombolysis
  • Access to endovascular treatment within 24 hours from onset.
  • In selected patients with acute ischemic stroke within 6 to 24 hours of onset must meet DAWN or DEFUSE 3 eligibility criteria.

You may not qualify if:

  • Proven occlusion of the cervical carotid artery
  • Disability prior to the stroke (modified ranking scale \>3)
  • Opposition of the patient or their family

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

wafaa mohamed farghaly, professor

CONTACT

01004489683wafmaf2002@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 9, 2018

First Posted

August 1, 2018

Study Start

October 30, 2018

Primary Completion

February 28, 2019

Study Completion

February 28, 2020

Last Updated

August 2, 2018

Record last verified: 2018-08